The Enterprise Value as of December 2024 (TTM) for Cytosorbents Corporation (CTSO) is 70.10M

According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 70.10M. This represents a change of 1.73% compared to the average of 68.90M of the last 4 quarters.

Cytosorbents Corporation (CTSO) Historical Enterprise Value (quarterly & annually)

How has CTSO Enterprise Value performed in the past?

The mean historical Enterprise Value of Cytosorbents Corporation over the last ten years is 144.68M. The current 70.10M Enterprise Value has changed 4.74% with respect to the historical average. Over the past ten years (40 quarters), CTSO's Enterprise Value was at its highest in in the September 2018 quarter at 380.71M. The Enterprise Value was at its lowest in in the September 2022 quarter at 50.10M.

Cytosorbents Corporation (CTSO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cytosorbents Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cytosorbents Corporation (CTSO) Average Enterprise Value

How has CTSO Enterprise Value performed in the past?

The current Enterprise Value of Cytosorbents Corporation (CTSO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cytosorbents Corporation (CTSO) Enterprise Value vs. Peers

How is CTSO’s Enterprise Value compared to its peers?

Cytosorbents Corporation’s Enterprise Value is greater than ProSomnus, Inc. (40.81M), less than LivaNova PLC (2.87B), less than Electromed, Inc. (236.41M), less than OrthoPediatrics Corp. (520.22M), less than Surmodics, Inc. (560.63M), less than NeuroPace, Inc. (390.59M), less than ClearPoint Neuro, Inc. (415.34M), less than TELA Bio, Inc. (136.88M), less than CVRx, Inc. (263.28M), less than Orthofix Medical Inc. (769.82M), less than Artivion, Inc. (1.50B), less than Heska Corporation (1.26B), less than Paragon 28, Inc. (931.28M), less than Inogen, Inc. (115.25M), less than Pulmonx Corporation (235.74M), less than Apyx Medical Corporation (77.23M),

Build a custom stock screener for Cytosorbents Corporation (CTSO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cytosorbents Corporation (CTSO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.